NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma

Concetta Saponaro1, Alessandro Vagheggini2, Emanuela Scarpi2

  • 1Functional Biomorphology Laboratory, IRCCS-Istituto Tumori "Giovanni Paolo II", 70124, Bari, Italy.

Abstract

Insights

The scaffolding protein NHERF1 influences breast cancer progression by interacting with tumor microenvironment (TME) factors. Cytoplasmic NHERF1 promotes cancer, while membranous NHERF1 acts as an oncosuppressor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The tumor microenvironment (TME) significantly impacts cancer progression.
  • The scaffolding protein NHERF1 has been implicated in breast cancer (BC) TME alterations.

Purpose of the Study:

  • To investigate the relationship between NHERF1 subcellular localization and TME markers in breast cancer.
  • To determine the prognostic significance of NHERF1 expression in relation to TME factors and patient survival.

Main Methods:

  • Immunohistochemistry on tissue microarrays (TMA) for NHERF1, VEGF, VEGFR1, HIF-1α, TWIST1, and MVD in 183 invasive BCs.
  • Immunofluorescence to analyze protein interactions and NHERF1's role in neovascularization.
  • Survival analyses correlating NHERF1 expression patterns with disease-free survival (DFS).

Main Results:

  • Cytoplasmic NHERF1 (cNHERF1) correlated with increased VEGF/VEGFR1 and decreased nuclear HIF-1α/TWIST1.
  • NHERF1-positive tumor cells were involved in neo-vascular formation.
  • Loss of nuclear TWIST1 (nTWIST1) and specific NHERF1/TWIST1 phenotypes significantly impacted DFS.

Conclusions:

  • NHERF1 exhibits a dynamic relationship with TME markers in breast cancer.
  • Membranous NHERF1 expression demonstrates an oncosuppressor role, whereas cytoplasmic NHERF1 displays oncogenic activity.
  • NHERF1 localization is a critical factor in breast cancer progression and patient prognosis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
787
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K